GMED
Globus Medical·NYSE
--
--(--)
--
--(--)
0.07 / 10
Underperform
GMED's fundamental profile is weak, highlighted by negative Asset-MV (-0.5007) and Revenue-MV (-0.0642) scores, while Cash-MV (0.2978) and Net Income-Revenue (0.2247) offer limited support. Ratios like ROA (7.68%) and net profit margin (10.24%) fall in higher quartiles, yet the overall fundamental score of 0.07 underscores vulnerability and justifies an underperform rating.
Analysis Checks(8/10)
Revenue-MV
Value-0.06
Score0/3
Weight613.18%
1M Return-3.84%
Value-0.06
Score0/3
Weight613.18%
1M Return-3.84%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight280.97%
1M Return-1.71%
Value100.00
Score2/3
Weight280.97%
1M Return-1.71%
Cash-UP
Value0.90
Score2/3
Weight684.97%
1M Return-4.86%
Value0.90
Score2/3
Weight684.97%
1M Return-4.86%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight316.78%
1M Return-1.95%
Value15.48
Score2/3
Weight316.78%
1M Return-1.95%
Cash-MV
Value0.30
Score2/3
Weight-707.67%
1M Return3.31%
Value0.30
Score2/3
Weight-707.67%
1M Return3.31%
ROA (%)
Value7.68
Score3/3
Weight-199.80%
1M Return1.03%
Value7.68
Score3/3
Weight-199.80%
1M Return1.03%
Net income-Revenue
Value0.22
Score2/3
Weight-563.89%
1M Return2.59%
Value0.22
Score2/3
Weight-563.89%
1M Return2.59%
Annualized net profit margin on total assets (%)
Value10.24
Score3/3
Weight-199.80%
1M Return1.03%
Value10.24
Score3/3
Weight-199.80%
1M Return1.03%
Asset-MV
Value-0.50
Score1/3
Weight110.48%
1M Return-0.63%
Value-0.50
Score1/3
Weight110.48%
1M Return-0.63%
Net profit / Total profit (%)
Value91.15
Score3/3
Weight-235.22%
1M Return1.20%
Value91.15
Score3/3
Weight-235.22%
1M Return1.20%
Revenue-MV
Value-0.06
Score0/3
Weight613.18%
1M Return-3.84%
Value-0.06
Score0/3
Weight613.18%
1M Return-3.84%
ROA (%)
Value7.68
Score3/3
Weight-199.80%
1M Return1.03%
Value7.68
Score3/3
Weight-199.80%
1M Return1.03%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight280.97%
1M Return-1.71%
Value100.00
Score2/3
Weight280.97%
1M Return-1.71%
Net income-Revenue
Value0.22
Score2/3
Weight-563.89%
1M Return2.59%
Value0.22
Score2/3
Weight-563.89%
1M Return2.59%
Cash-UP
Value0.90
Score2/3
Weight684.97%
1M Return-4.86%
Value0.90
Score2/3
Weight684.97%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value10.24
Score3/3
Weight-199.80%
1M Return1.03%
Value10.24
Score3/3
Weight-199.80%
1M Return1.03%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight316.78%
1M Return-1.95%
Value15.48
Score2/3
Weight316.78%
1M Return-1.95%
Asset-MV
Value-0.50
Score1/3
Weight110.48%
1M Return-0.63%
Value-0.50
Score1/3
Weight110.48%
1M Return-0.63%
Cash-MV
Value0.30
Score2/3
Weight-707.67%
1M Return3.31%
Value0.30
Score2/3
Weight-707.67%
1M Return3.31%
Net profit / Total profit (%)
Value91.15
Score3/3
Weight-235.22%
1M Return1.20%
Value91.15
Score3/3
Weight-235.22%
1M Return1.20%
Is GMED undervalued or overvalued?
- GMED scores 0.07/10 on fundamentals and holds a Premium valuation at present. Backed by its 9.26% ROE, 15.30% net margin, 27.73 P/E ratio, 2.67 P/B ratio, and 404.84% earnings growth, these metrics solidify its Underperform investment rating.
